Schizophrenia and Disorders With Psychotic Features Completed Phase 2 Trials for Minocycline (DB01017)

Also known as: Schizophrenia and Disorders With Psychotic Feature

IndicationStatusPhase
DBCOND0031274 (Schizophrenia and Disorders With Psychotic Features)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02928965The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and MechanismsTreatment